04/23/2024
3:17 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:25 PM | BAKER BROS. ADVISORS LP (Filed by)
TScan Therapeutics (Subject)
| Form SC 13D/A | |
04/23/2024
3:15 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
8:58 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/17/2024
5:25 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:20 AM | TScan Therapeutics (Subject)
| Form FWP | |
04/16/2024
4:21 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
|
04/16/2024
3:16 PM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2024
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
04/10/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K/A | |
04/08/2024
7:17 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
5:02 AM | Pitango HealthTech Fund I, L.P. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024
6:45 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
3:21 PM | Amello Jason (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:00 PM | BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
5:01 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
7:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:15 AM | TScan Therapeutics (Issuer)
TScan Therapeutics (Issuer)
Woods Keith (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/08/2023
7:20 AM | TScan Therapeutics (Issuer)
TScan Therapeutics (Issuer)
Woods Keith (Reporting)
Woods Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
6:39 PM | Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
6:31 PM | Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/29/2023
7:30 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:38 PM | TScan Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2023
5:25 PM | BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:01 PM | TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:08 PM | MacBeath Gavin (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:09 PM | Silver Brian M. (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:13 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:14 PM | Gruia Gabriela (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:17 PM | Dorton Katina (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:19 PM | Barton Debora (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:40 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump is sounding the alarm (Ad) Europe is one of the latest to release a central bank digital currency and along with it, new cash rules. Christine Lagarde, President of the European Central Bank, shared "Now we have in Europe this threshold, above 1,000 euros you cannot pay cash… if you get caught you are fined or you are going to jail".
Are you prepared? Click here to get your complimentary retirement guide! |
06/08/2023
12:25 PM | BlackRock Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
06/06/2023
6:53 PM | BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:45 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
06/02/2023
4:33 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/02/2023
4:35 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
7:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
7:16 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
7:12 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
05/26/2023
5:42 AM | TScan Therapeutics (Subject)
| Form FWP | |
05/17/2023
7:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2023
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
05/16/2023
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
05/16/2023
4:19 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
05/16/2023
4:21 PM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
3:42 PM | SOUTHWELL DAVID P (Reporting)
TScan Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023
6:31 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023
6:16 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
8:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
